Spectral AI, Inc. MDAI
At closeNov 6, 2026, 4:50 PM EST
After hours · Nov 6, 4:50 PM ET
- YTD
- +4.93%
- 1 year
- -23.20%
- Market cap
- 47.96M
- Revenue (ttm)
- 27.26M
- Profit margin
- -40.78%
- EPS (ttm)
- -0.32
- Shares out
- 20.75M
- Forward P/E
- -3.75
- YTD return
- +4.93%
- 1-year return
- -23.20%
- Volume
- 166.80K
- Avg volume
- 137.97K
- Open
- 1.41
- Previous close
- 1.38
- Day's range
- 1.40 – 1.53
- 52-week range
- 1.20 – 2.68
- Analysts
- Buy
- Price target
- 4.93 (+231.1%)
- Earnings date
- Aug 12, 2024
2Y -0.02 (-1.32%)
Key statistics
- Enterprise value
- 38.11M
- PEG ratio
- 0.00
- Price / sales
- 1.60
- Price / book
- 0.00
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Revenue growth
- 137.60%
- Free cash flow
- -7.45M
- Total cash
- 3.70M
- Total debt
- 8.06M
- Return on equity
- 0.00%
- Short % of float
- 26.55%
- 50-day average
- 1.56
- 200-day average
- 1.66
Analyst view
Consensus: buy
- Target (low)
- 3.00
- Target (mean)
- 4.93
- Target (high)
- 8.10
- Strong buy1
- Buy3
- Hold1
- Sell0
- Strong sell0
Next earnings
Aug 12, 2024
Expected Aug 12, 2024. Consensus EPS estimate -0.14.
Financials — quick view
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Nov 6, 2024 | Sep 1, 2024 | -0.14 | -0.02 | +0.12 | +85.71% |
| Aug 12, 2024 | Jun 1, 2024 | -0.14 | -0.16 | -0.02 | -14.29% |
| Aug 12, 2024 | Jun 1, 2024 | -0.14 | — | — | — |
| May 7, 2024 | Mar 1, 2024 | 0.00 | — | — | — |
| May 7, 2024 | Mar 1, 2024 | 0.00 | -0.19 | — | — |
| Mar 27, 2024 | Dec 1, 2023 | 0.00 | -0.22 | — | — |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Aug 13, 2024 | HC Wainwright & Co. | reit | Buy | Buy |
| Aug 12, 2024 | Northland Capital Markets | init | — | Outperform |
| Jul 18, 2024 | HC Wainwright & Co. | init | — | Buy |
| Jan 23, 2024 | BTIG | init | — | Buy |
About Spectral AI, Inc.
Spectral AI, Inc., an artificial intelligence (AI) company, focuses on developing predictive medical diagnostics in the United States. The company develops medical diagnostics for faster and accurate treatment decisions in wound care with applications involving patients with burns and diabetic foot ulcers. Its products include DeepView System, a predictive analytics platform integrated with the predictive AI-Burn, which combines AI algorithms and multispectral imaging (MSI) imaging for an assessment of wound healing potential and offers clinicians an objective and immediate assessment of a wound's healing potential prior to treatment or other medical intervention; and DeepView SnapShot M, a handheld, portable, and wireless diagnostic tool, that provides a potential enhanced and expanded use for the government and emergency care, first responders, and potentially home health care professionals. The company is headquartered in Dallas, Texas.
- Sector
- Healthcare
- Industry
- Medical Devices
- Country
- United States
- Website
- spectral-ai.com
News
Spectral AI To Present Data Titled Artificial Intelligence Training & Validation Of Multi-spectral Imaging Device For Evaluation Of Burn Wounds At ACS Clinical Congress 2026
Why JOYY Shares Are Trading Higher By 12%; Here Are 20 Stocks Moving Premarket
Earnings Scheduled For May 12, 2026
12 Health Care Stocks Moving In Tuesday's After-Market Session
Earnings Scheduled For March 24, 2026
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Why Five Below Shares Are Trading Higher By Around 7%; Here Are 20 Stocks Moving Premarket
12 Health Care Stocks Moving In Wednesday's After-Market Session
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Your note
Sign in to keep a note on MDAI — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| CAPONE VINCENT S | General Counsel | Stock Award(Grant) | May 9, 2024 | 19,700 |
| CARLSON PETER M | Chief Executive Officer | Stock Award(Grant) | May 9, 2024 | 29,411 |
| COTTON RICHARD JOHN | Director | Stock Award(Grant) | Nov 16, 2023 | 47,529 |
| DIMAIO JOHN MICHAEL | Director and Beneficial Owner of more than 10% of a Class of Security | Purchase | May 9, 2024 | 2,491,910 |
| EDMONDS FRANKLIN S JR | Director | Conversion of Exercise of derivative security | Sep 10, 2023 | 20,000 |
| MICEK STAN | Chief Operating Officer | Stock Award(Grant) | May 9, 2024 | 10,000 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Highlander Partners, L.P. | 4.61% | 900,000 | 1.89M | Sep 29, 2024 |
| Stifel Financial Corporation | 3.89% | 758,584 | 1.59M | Sep 29, 2024 |
| Rathbones Group PLC | 2.24% | 436,122 | 915.86K | Sep 29, 2024 |
| University of Texas/Texas AM Investment Managment Co | 1.08% | 210,488 | 442.02K | Sep 29, 2024 |
| Avantax Planning Partners, Inc. | 0.82% | 159,852 | 335.69K | Sep 29, 2024 |
| Morgan Stanley | 0.58% | 114,122 | 239.66K | Sep 29, 2024 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Vanguard Extended Market Index Fund | 0.32% | 61,531 | 129.22K | Sep 29, 2024 |
| Fidelity Extended Market Index Fund | 0.25% | 49,043 | 102.99K | Oct 30, 2024 |
| Vanguard Total Stock Market Index Fund | 0.22% | 43,872 | 92.13K | Sep 29, 2024 |
| iShares Micro Cap ETF | 0.12% | 23,164 | 48.64K | Oct 30, 2024 |
| Fidelity Total Market Index Fund | 0.07% | 13,663 | 28.69K | Oct 30, 2024 |
| Fidelity Series Total Market Index Fund | 0.06% | 11,713 | 24.60K | Oct 30, 2024 |
